MedTrace Logo

Victus Versus Conventional

NCT01991717 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2014-01-22

No results posted yet for this study

Summary

Cataract surgery is among the world's most frequently performed operations. It involves removal of an opaque lens from the human eye and implantation of an artificial lens. The operation is performed under local anaesthesia using ultrasound technology, by which the lens is emulsified and removed by suction.

Femtosecond laser-assisted cataract surgery is a new innovative surgical procedure that can improve the quality of cataract surgery and provide a new best possible standard of quality. In contrast to the conventional method the capsulotomy and the fragemntation are fully automatically performed with a femtosecond laser. In addition, the lens is fragmented by the laser, which substantially facilitates its removal and reduces the operation time.

Study to investigate whether the femtosecond laser cataract surgery causes any significant differences in clinical outcomes as compared to the conventional, manual continuous curvilinear capsulorhexis (CCC).

Effective phako time (EPT) is defined as duration of phakoemulsifikation of the crystalline lens.

EPT of conventional surgery at intraoperative visit \> EPT oflaser-assisted surgery at intraoperative visit

Conditions

  • Cataract

Interventions

DEVICE

Victus

The anterior capsulotomy and lens fragmentation will be performed by means of femtosecond laser surgery

DEVICE

Conventional Phaco

The capsulotomy as well as the lens fragmentation is performed manually.

Sponsors & Collaborators

  • Technolas Perfect Vision GmbH

    collaborator INDUSTRY

  • Matthias Bolz

    lead OTHER

Principal Investigators

  • Matthias Bolz, MD · AKh Linz, Ophthalmology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01991717 on ClinicalTrials.gov